ATE209659T1 - Breit-reaktive opsonische antikörper, die mit gemeinsamen staphylococcus-antigenen reagieren - Google Patents

Breit-reaktive opsonische antikörper, die mit gemeinsamen staphylococcus-antigenen reagieren

Info

Publication number
ATE209659T1
ATE209659T1 AT95933880T AT95933880T ATE209659T1 AT E209659 T1 ATE209659 T1 AT E209659T1 AT 95933880 T AT95933880 T AT 95933880T AT 95933880 T AT95933880 T AT 95933880T AT E209659 T1 ATE209659 T1 AT E209659T1
Authority
AT
Austria
Prior art keywords
react
broadly reactive
opsonic antibodies
common staphylococcus
staphylococcus antigens
Prior art date
Application number
AT95933880T
Other languages
English (en)
Inventor
Gerald W Fisher
Original Assignee
Jackson H M Found Military Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23194201&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE209659(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jackson H M Found Military Med filed Critical Jackson H M Found Military Med
Application granted granted Critical
Publication of ATE209659T1 publication Critical patent/ATE209659T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT95933880T 1994-09-21 1995-09-21 Breit-reaktive opsonische antikörper, die mit gemeinsamen staphylococcus-antigenen reagieren ATE209659T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30849594A 1994-09-21 1994-09-21
PCT/US1995/011992 WO1996009321A1 (en) 1994-09-21 1995-09-21 Broadly reactive opsonic antibodies reactive with common staphylococcal antigens

Publications (1)

Publication Number Publication Date
ATE209659T1 true ATE209659T1 (de) 2001-12-15

Family

ID=23194201

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95933880T ATE209659T1 (de) 1994-09-21 1995-09-21 Breit-reaktive opsonische antikörper, die mit gemeinsamen staphylococcus-antigenen reagieren

Country Status (10)

Country Link
EP (1) EP0783520B1 (de)
JP (1) JP4160633B2 (de)
AT (1) ATE209659T1 (de)
AU (1) AU707298B2 (de)
CA (1) CA2200691C (de)
DE (1) DE69524242T2 (de)
DK (1) DK0783520T3 (de)
ES (1) ES2169153T3 (de)
PT (1) PT783520E (de)
WO (1) WO1996009321A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
IT1298539B1 (it) * 1998-02-03 2000-01-12 Bracco Spa Metodo per la determinazione di infezioni da protesi
US7250494B2 (en) 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
EP2340848A3 (de) * 2004-10-21 2011-09-14 Wyeth LLC Immunogene Zusammensetzungen von Staphylococcus epidermidis Polypeptide und Polynucleotide Antigenen
BRPI1015567A2 (pt) 2009-06-22 2021-08-31 Wyeth Llc Composições imunogênicas de antígenos de staphylococcus aureus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU681573B2 (en) * 1991-11-22 1997-09-04 Glaxosmithkline Biologicals Sa Type I and type II surface antigens associated with (staphylococcus epidermidis)
WO1993019373A1 (en) * 1992-03-19 1993-09-30 U.S. GOVERNMENT, as represented by THE SECRETARY O Broadly reactive opsonic antibodies that react with common staphylococcal antigens

Also Published As

Publication number Publication date
CA2200691A1 (en) 1996-03-28
ES2169153T3 (es) 2002-07-01
AU707298B2 (en) 1999-07-08
EP0783520A1 (de) 1997-07-16
DK0783520T3 (da) 2002-03-25
PT783520E (pt) 2002-05-31
DE69524242T2 (de) 2002-05-23
JP4160633B2 (ja) 2008-10-01
JP2000509961A (ja) 2000-08-08
AU3637195A (en) 1996-04-09
EP0783520B1 (de) 2001-11-28
CA2200691C (en) 2011-02-15
WO1996009321A1 (en) 1996-03-28
DE69524242D1 (de) 2002-01-10

Similar Documents

Publication Publication Date Title
ATE197506T1 (de) Breitreaktive opsonische antikörper die mit gemeinsamen antigenen von staphylococcus reagieren
DE60112744T2 (de) Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigens
DK0986577T3 (da) Opsonisk og beskyttende monoklonale og kimære antistoffer specifikke for lipoteichoicsyre af grampositive bakterier
ATE165395T1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
EP0077734A3 (de) Herstellung von monoklonalen Antikörpern gegen bakterielle Adhesine
TR200200633T2 (tr) Yeni streptococcus antijenleri
CA2381770A1 (en) Human ctla-4 antibodies and their uses
MX9603773A (es) Anticuerpos monoclonales anti-interleucina-8 para el tratamiento de trastornos inflamatorios.
PT827512E (pt) Anticorpo especifico para staphylococcus aureus e sua utilizacao
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
DE69928384D1 (de) Behandlung und nachweis von staphylokokkeninfektionen
EP0350690A3 (de) Neutralisation der in vitro- und in vivo-toxischen Eigenschaften von TNF-alfa durch monoklonale Antikörper und die davon abgeleiteten Fragmente
DK1167389T3 (da) Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
GR3025630T3 (en) Monoclonal antibody against human IgE
EP0683822A4 (de) Herstellung von photoprotein konjugaten und verfahren zu ihrer verwendung.
TR200103432T2 (tr) Engelleyici monoklonal VLA-1 antikoru ve enflamasyonlu hastalıkların tedavisinde kullanımı.
ATE209659T1 (de) Breit-reaktive opsonische antikörper, die mit gemeinsamen staphylococcus-antigenen reagieren
NO973875D0 (no) Fremgangsmåte for simulering av en immunrespons
FI934963A7 (fi) CTAA 81AV78, monoklonaalisen 81AV78-humaanivasta-aineen tunnistama ant igeeni
PT998493E (pt) Epitopos de toxina semelhante a shigella e a sua utilizacao como vacinas e em diagnosticos
CA2297694A1 (en) Antibodies and diagnostic methods for the diagnosis of pestviruses
DE68924963D1 (de) Zusammensetzungen und Methoden zur Behandlung und Vorbeugung von Gram-Negativen-Infektionen.
EP0450573A3 (de) Antikörper für die Behandlung und die Diagnose von Pseudomonas aeruginosa Infektionen
ITTO911003A1 (it) Metodo rapido per l'identificazione dello s. aureus, kit diagnostico per l'esecuzione di tale metodo, anticorpi monoclonali contro la glucosaminidasi dello s. aureus e ibridoma per la produzione di tali anticorpi.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification